The problem is that this is only the case because you can either buy Anthropic or nothing, because the only other pureplay AI competition (OAI) decided to postpone the IPO. That is where the current open valuation comes from. The top models are more or less fungible and there is no way to capture the b2b side like MS, if the safeguard bullshit or some other stuff continues to act up the switch is pretty easy.
My point is that Anthropic is not the pure AI play that people seem to think it is. At the end of the day there are no pure AI plays. Their revenue is not coming from mathematicians solving unsolved problems and the invention of new pharmaceuticals (yet). Their revenue is coming from companies like Eli Lilly paying them a half billion dollars a year to provide for them B2B software. A hundred Lilly employees could say "we hate Outlook switch us to Google" and their leadership will not listen. Similarly, Opus 5.5 is far past the point of being useful and powerful enough that customers are less interested in capabilities, and more interested in "how can you help me deploy those capabilities". No one has a better story for that than Anthropic, and I don't think anyone else is getting close either.